Molecular matched targeted therapies for primary brain tumors - a single center retrospective analysis

to connected objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Journal of neuro-oncology, 159.2022, 2, S. 243-259

Event: Veröffentlichung

(where): Frankfurt am Main

(who): Universitätsbibliothek Johann Christian Senckenberg

(when): 2022

Creator: Luger, Anna-Luisa
König, Sven
Samp, Patrick Felix
Urban, Hans
Divé, Iris
Burger, Michael C.
Voss, Martin
Franz, Kea
Fokas, Emmanouil
Filipski, Katharina Johanna
Demes, Melanie Christin
Stenzinger, Albrecht
Sahm, Felix
Reuss, David
Harter, Patrick Nikolaus
Wagner, Sebastian Alexander
Hattingen, Elke
Wichert, Jennifer
Lapa, Constantin Frederik Victor
Fröhling, Stefan
Steinbach, Joachim Peter
Ronellenfitsch, Michael Wilfried

DOI: 10.1007/s11060-022-04049-w

URN: urn:nbn:de:hebis:30:3-694670

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 25.03.2025, 1:48 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Luger, Anna-Luisa
König, Sven
Samp, Patrick Felix
Urban, Hans
Divé, Iris
Burger, Michael C.
Voss, Martin
Franz, Kea
Fokas, Emmanouil
Filipski, Katharina Johanna
Demes, Melanie Christin
Stenzinger, Albrecht
Sahm, Felix
Reuss, David
Harter, Patrick Nikolaus
Wagner, Sebastian Alexander
Hattingen, Elke
Wichert, Jennifer
Lapa, Constantin Frederik Victor
Fröhling, Stefan
Steinbach, Joachim Peter
Ronellenfitsch, Michael Wilfried
Universitätsbibliothek Johann Christian Senckenberg

Time of origin

2022

Other Objects (12)

Molecular matched targeted therapies for primary brain tumors—a single center retrospective analysis

"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom

Developing targeted therapies for pediatric PFA ependymoma

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells

Prostate cancer stem cells: Clinical aspects and targeted therapies

Hochschulschrift

Mouse models and targeted therapies for RAS-driven tumours

$Improved efficacy of tafasitamab plus lenalidomide versus systemic therapies for relapsed/refractory DLBCL: RE-MIND2, an observational retrospective matched cohort study$

Improved efficacy of tafasitamab plus lenalidomide versus systemic therapies for relapsed/refractory DLBCL: RE-MIND2, an observational retrospective matched cohort study

Targeted therapies for the treatment of triple-negative breast cancer

Network meta-analysis for the integrated evaluation of targeted therapies

Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis

Hochschulschrift

Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma

Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies

Molecular matched targeted therapies for primary brain tumors—a single center retrospective analysis

"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom

Developing targeted therapies for pediatric PFA ependymoma

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells

Prostate cancer stem cells: Clinical aspects and targeted therapies

Hochschulschrift

Mouse models and targeted therapies for RAS-driven tumours

$Improved efficacy of tafasitamab plus lenalidomide versus systemic therapies for relapsed/refractory DLBCL: RE-MIND2, an observational retrospective matched cohort study$

Improved efficacy of tafasitamab plus lenalidomide versus systemic therapies for relapsed/refractory DLBCL: RE-MIND2, an observational retrospective matched cohort study

Targeted therapies for the treatment of triple-negative breast cancer

Network meta-analysis for the integrated evaluation of targeted therapies

Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis

Hochschulschrift

Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma

Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies

Molecular matched targeted therapies for primary brain tumors—a single center retrospective analysis

"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom

Developing targeted therapies for pediatric PFA ependymoma

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells

Prostate cancer stem cells: Clinical aspects and targeted therapies

Hochschulschrift

Mouse models and targeted therapies for RAS-driven tumours

$Improved efficacy of tafasitamab plus lenalidomide versus systemic therapies for relapsed/refractory DLBCL: RE-MIND2, an observational retrospective matched cohort study$

Improved efficacy of tafasitamab plus lenalidomide versus systemic therapies for relapsed/refractory DLBCL: RE-MIND2, an observational retrospective matched cohort study

Targeted therapies for the treatment of triple-negative breast cancer

Network meta-analysis for the integrated evaluation of targeted therapies

Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis

Hochschulschrift

Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma

Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Molecular matched targeted therapies for primary brain tumors - a single center retrospective analysis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Molecular matched targeted therapies for primary brain tumors—a single center retrospective analysis

"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom

Developing targeted therapies for pediatric PFA ependymoma

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells

Prostate cancer stem cells: Clinical aspects and targeted therapies

Mouse models and targeted therapies for RAS-driven tumours

Improved efficacy of tafasitamab plus lenalidomide versus systemic therapies for relapsed/refractory DLBCL: RE-MIND2, an observational retrospective matched cohort study

Targeted therapies for the treatment of triple-negative breast cancer

Network meta-analysis for the integrated evaluation of targeted therapies

Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis

Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma

Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies

Molecular matched targeted therapies for primary brain tumors—a single center retrospective analysis

"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom

Developing targeted therapies for pediatric PFA ependymoma

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells

Prostate cancer stem cells: Clinical aspects and targeted therapies

Mouse models and targeted therapies for RAS-driven tumours

Improved efficacy of tafasitamab plus lenalidomide versus systemic therapies for relapsed/refractory DLBCL: RE-MIND2, an observational retrospective matched cohort study

Targeted therapies for the treatment of triple-negative breast cancer

Network meta-analysis for the integrated evaluation of targeted therapies

Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis

Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma

Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies

Molecular matched targeted therapies for primary brain tumors—a single center retrospective analysis

"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom

Developing targeted therapies for pediatric PFA ependymoma

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells

Prostate cancer stem cells: Clinical aspects and targeted therapies

Mouse models and targeted therapies for RAS-driven tumours

Improved efficacy of tafasitamab plus lenalidomide versus systemic therapies for relapsed/refractory DLBCL: RE-MIND2, an observational retrospective matched cohort study

Targeted therapies for the treatment of triple-negative breast cancer

Network meta-analysis for the integrated evaluation of targeted therapies

Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis

Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma

Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies

Related objects

Reset password